miCure Therapeutics

MicroRNA Therapeutics for CNS Disorders

Health Tech & Life Sciences
non-active
Mature Tel Aviv-Yafo, Israel Founded 2013
LinkedIn
Last updated 2026-06-18
Total raised
$2.0M
Last: 2014-12
Stage
Mature
Founded
2013
Headcount
3
HQ
Tel Aviv-Yafo, Israel
Sector
Health Tech & Life Sciences

About

miCure Therapeutics is a biotechnology company leveraging microRNA-based therapeutics and diagnostics for neurodegenerative and psychiatric disorders. Its microRNA therapeutics and diagnostics for central nervous system (CNS) disorders are based on inventions by Professor Alon Chen of the Department of Neurobiology and Dr. Eran Hornstein of the Department of Molecular Genetics at the Weizmann Institute of Science. miCure Therapeutics miR-135 is being developed to treat mood disorders, in particular major depression and treatment-resistant depression, a major unmet medical need with few therapeutic options currently available for patients and physicians. miR-135 targets, among others, two important gene transcripts, Htr1a (serotonin receptor-1a) and Slc6a4 (serotonin transporter), both essential for intact serotonergic neuronal activity.

Funding history · 1 round · $2.0M total

2014-12

Q&A

What is miCure Therapeutics' primary focus?
miCure Therapeutics is a biotechnology company focused on leveraging microRNA-based therapeutics and diagnostics for neurodegenerative and psychiatric disorders, specifically developing miR-135 to treat mood disorders like major depression.
When was miCure Therapeutics founded?
miCure Therapeutics was founded in September 2013.
What is the current operational status of miCure Therapeutics?
miCure Therapeutics is currently non-active and ceased to operate in March 2026.
How much funding has miCure Therapeutics raised in total?
miCure Therapeutics has raised a total of $2,000,000.
How many employees does miCure Therapeutics have?
miCure Therapeutics has 1-10 employees.
What is the primary sector of miCure Therapeutics?
miCure Therapeutics operates in the Health Tech & Life Sciences sector.
Does miCure Therapeutics hold any patents?
Yes, miCure Therapeutics holds 1 patent.

Team · 2

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDrug Delivery
Technologies
BiologicalsCells
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcareProviders
Business model
B2B

Highlights

1 Patents

Tags

cns-disordersbiological-therapybiomarkersgeneticsmental-healthneurologydegenerative-diseasescell-therapypsychiatrydrug-designpharmaceuticalspharma-companieshospitals
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)